KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Clorox (CLX) over the last 17 years, with Jun 2025 value amounting to $264.0 million.

  • Clorox's Gains from Investment Securities rose 140.00% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $271.0 million, marking a year-over-year decrease of 23.01%. This contributed to the annual value of $264.0 million for FY2025, which is 23.92% down from last year.
  • Clorox's Gains from Investment Securities amounted to $264.0 million in FY2025, which was down 23.92% from $347.0 million recorded in FY2024.
  • Over the past 5 years, Clorox's Gains from Investment Securities peaked at $347.0 million during FY2024, and registered a low of $73.0 million during FY2023.
  • For the 3-year period, Clorox's Gains from Investment Securities averaged around $228.0 million, with its median value being $264.0 million (2025).
  • As far as peak fluctuations go, Clorox's Gains from Investment Securities tumbled by 67.00% in 2022, and later surged by 375.34% in 2024.
  • Clorox's Gains from Investment Securities (Yearly) stood at $303.0 million in 2021, then slumped by 67.00% to $100.0 million in 2022, then decreased by 27.00% to $73.0 million in 2023, then soared by 375.34% to $347.0 million in 2024, then declined by 23.92% to $264.0 million in 2025.